Report from the Society for Biological Therapy and Vascular Biology Faculty of the NCI Workshop on Angiogenesis Monitoring

Donald M. McDonald, Beverly A. Teicher, William Stetler-Stevenson, Sylvia S W Ng, William D. Figg, Judah Folkman, Douglas Hanahan, Robert Auerbach, Michael O'Reilly, Roy Herbst, David Cheresh, Michael Gordon, Alexander Eggermont, Steven K. Libutti

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The field of tumor angiogenesis has seen explosive growth over the last 5 years. Preclinical as well as early clinical evaluation of novel compounds is progressing at a rapid pace. To gain a perspective on the field and to take stock of advances in the understanding of molecular mechanisms underlying the process of tumor angiogenesis as well as ways of monitoring the activity of agents, the Society for Biologic Therapy and the National Cancer Institute's Vascular Biology Faculty convened a Workshop on Angiogenesis Monitoring in November 2002. The Workshop was composed of invited speakers and participants from academia, industry, and government. It was divided into 3 sessions, each chaired by leaders in the field. The first focused on advances in the understanding of the cellular and molecular mechanisms of angiogenesis in tumors. The second examined preclinical assay systems that are useful in vascular biology. The third addressed the translation to the clinic and monitoring of antiangiogenic activity of agents in patients and novel trial designs. What follows is a summary of the discussions and findings of each session.

Original languageEnglish (US)
Pages (from-to)161-175
Number of pages15
JournalJournal of Immunotherapy
Volume27
Issue number2
StatePublished - Mar 2004
Externally publishedYes

Fingerprint

Biological Therapy
Blood Vessels
Education
Neoplasms
Angiogenesis Inhibitors
National Cancer Institute (U.S.)
Industry
Growth

Keywords

  • Angiogenesis
  • Models
  • Therapy
  • Tumor

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Immunology

Cite this

McDonald, D. M., Teicher, B. A., Stetler-Stevenson, W., Ng, S. S. W., Figg, W. D., Folkman, J., ... Libutti, S. K. (2004). Report from the Society for Biological Therapy and Vascular Biology Faculty of the NCI Workshop on Angiogenesis Monitoring. Journal of Immunotherapy, 27(2), 161-175.

Report from the Society for Biological Therapy and Vascular Biology Faculty of the NCI Workshop on Angiogenesis Monitoring. / McDonald, Donald M.; Teicher, Beverly A.; Stetler-Stevenson, William; Ng, Sylvia S W; Figg, William D.; Folkman, Judah; Hanahan, Douglas; Auerbach, Robert; O'Reilly, Michael; Herbst, Roy; Cheresh, David; Gordon, Michael; Eggermont, Alexander; Libutti, Steven K.

In: Journal of Immunotherapy, Vol. 27, No. 2, 03.2004, p. 161-175.

Research output: Contribution to journalArticle

McDonald, DM, Teicher, BA, Stetler-Stevenson, W, Ng, SSW, Figg, WD, Folkman, J, Hanahan, D, Auerbach, R, O'Reilly, M, Herbst, R, Cheresh, D, Gordon, M, Eggermont, A & Libutti, SK 2004, 'Report from the Society for Biological Therapy and Vascular Biology Faculty of the NCI Workshop on Angiogenesis Monitoring', Journal of Immunotherapy, vol. 27, no. 2, pp. 161-175.
McDonald DM, Teicher BA, Stetler-Stevenson W, Ng SSW, Figg WD, Folkman J et al. Report from the Society for Biological Therapy and Vascular Biology Faculty of the NCI Workshop on Angiogenesis Monitoring. Journal of Immunotherapy. 2004 Mar;27(2):161-175.
McDonald, Donald M. ; Teicher, Beverly A. ; Stetler-Stevenson, William ; Ng, Sylvia S W ; Figg, William D. ; Folkman, Judah ; Hanahan, Douglas ; Auerbach, Robert ; O'Reilly, Michael ; Herbst, Roy ; Cheresh, David ; Gordon, Michael ; Eggermont, Alexander ; Libutti, Steven K. / Report from the Society for Biological Therapy and Vascular Biology Faculty of the NCI Workshop on Angiogenesis Monitoring. In: Journal of Immunotherapy. 2004 ; Vol. 27, No. 2. pp. 161-175.
@article{9222f3fe44f1461ab27791c5f112b126,
title = "Report from the Society for Biological Therapy and Vascular Biology Faculty of the NCI Workshop on Angiogenesis Monitoring",
abstract = "The field of tumor angiogenesis has seen explosive growth over the last 5 years. Preclinical as well as early clinical evaluation of novel compounds is progressing at a rapid pace. To gain a perspective on the field and to take stock of advances in the understanding of molecular mechanisms underlying the process of tumor angiogenesis as well as ways of monitoring the activity of agents, the Society for Biologic Therapy and the National Cancer Institute's Vascular Biology Faculty convened a Workshop on Angiogenesis Monitoring in November 2002. The Workshop was composed of invited speakers and participants from academia, industry, and government. It was divided into 3 sessions, each chaired by leaders in the field. The first focused on advances in the understanding of the cellular and molecular mechanisms of angiogenesis in tumors. The second examined preclinical assay systems that are useful in vascular biology. The third addressed the translation to the clinic and monitoring of antiangiogenic activity of agents in patients and novel trial designs. What follows is a summary of the discussions and findings of each session.",
keywords = "Angiogenesis, Models, Therapy, Tumor",
author = "McDonald, {Donald M.} and Teicher, {Beverly A.} and William Stetler-Stevenson and Ng, {Sylvia S W} and Figg, {William D.} and Judah Folkman and Douglas Hanahan and Robert Auerbach and Michael O'Reilly and Roy Herbst and David Cheresh and Michael Gordon and Alexander Eggermont and Libutti, {Steven K.}",
year = "2004",
month = "3",
language = "English (US)",
volume = "27",
pages = "161--175",
journal = "Journal of Immunotherapy",
issn = "1053-8550",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Report from the Society for Biological Therapy and Vascular Biology Faculty of the NCI Workshop on Angiogenesis Monitoring

AU - McDonald, Donald M.

AU - Teicher, Beverly A.

AU - Stetler-Stevenson, William

AU - Ng, Sylvia S W

AU - Figg, William D.

AU - Folkman, Judah

AU - Hanahan, Douglas

AU - Auerbach, Robert

AU - O'Reilly, Michael

AU - Herbst, Roy

AU - Cheresh, David

AU - Gordon, Michael

AU - Eggermont, Alexander

AU - Libutti, Steven K.

PY - 2004/3

Y1 - 2004/3

N2 - The field of tumor angiogenesis has seen explosive growth over the last 5 years. Preclinical as well as early clinical evaluation of novel compounds is progressing at a rapid pace. To gain a perspective on the field and to take stock of advances in the understanding of molecular mechanisms underlying the process of tumor angiogenesis as well as ways of monitoring the activity of agents, the Society for Biologic Therapy and the National Cancer Institute's Vascular Biology Faculty convened a Workshop on Angiogenesis Monitoring in November 2002. The Workshop was composed of invited speakers and participants from academia, industry, and government. It was divided into 3 sessions, each chaired by leaders in the field. The first focused on advances in the understanding of the cellular and molecular mechanisms of angiogenesis in tumors. The second examined preclinical assay systems that are useful in vascular biology. The third addressed the translation to the clinic and monitoring of antiangiogenic activity of agents in patients and novel trial designs. What follows is a summary of the discussions and findings of each session.

AB - The field of tumor angiogenesis has seen explosive growth over the last 5 years. Preclinical as well as early clinical evaluation of novel compounds is progressing at a rapid pace. To gain a perspective on the field and to take stock of advances in the understanding of molecular mechanisms underlying the process of tumor angiogenesis as well as ways of monitoring the activity of agents, the Society for Biologic Therapy and the National Cancer Institute's Vascular Biology Faculty convened a Workshop on Angiogenesis Monitoring in November 2002. The Workshop was composed of invited speakers and participants from academia, industry, and government. It was divided into 3 sessions, each chaired by leaders in the field. The first focused on advances in the understanding of the cellular and molecular mechanisms of angiogenesis in tumors. The second examined preclinical assay systems that are useful in vascular biology. The third addressed the translation to the clinic and monitoring of antiangiogenic activity of agents in patients and novel trial designs. What follows is a summary of the discussions and findings of each session.

KW - Angiogenesis

KW - Models

KW - Therapy

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=10744230105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744230105&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 161

EP - 175

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1053-8550

IS - 2

ER -